Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495573 · ClinicalTrials.gov registry record
HSV-2 Shedding Resolution After Acyclovir Treatment
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 36
- Enrollment target
NCT00495573: Completed study, sponsored by University of Washington.
NCT00495573 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00495573 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the pattern of viral shedding after beginning treatment with acyclovir for a clinical recurrence of genital herpes and to compare it with the pattern of viral shedding during an untreated clinical recurrence of genital herpes.
Interventions
- DRUG acyclovir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2007-06 |
| Est. Completion | 2012-03 |
What the finished NCT00495573 record still lists
NCT00495573 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which acyclovir is the first listed.
NCT00495573 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00495573 about?
NCT00495573 is a clinical study titled "HSV-2 Shedding Resolution After Acyclovir Treatment". The purpose of the study is to evaluate the pattern of viral shedding after beginning treatment with acyclovir for a clinical recurrence of genital herpes and to compare it with the pattern of viral shedding during an untreated clinical recurrence of genital herpes.
What is the current status of trial NCT00495573?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2007-06. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00495573?
The interventions under investigation include: acyclovir (DRUG).
Who is sponsoring clinical trial NCT00495573?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia